Behind the Scenes of Pfizer's Latest Options Trends
Portfolio Pulse from Benzinga Insights
Investors have shown a bullish stance on Pfizer (NYSE:PFE) through significant options trading activity, with a mix of 58% bullish and 41% bearish sentiment among big-money traders. A total of 17 options trades were spotted, with a notable preference for calls over puts. The trades suggest a price target range of $25.0 to $30.0 for Pfizer. Currently, Pfizer's stock is down by -2.13%, trading at $27.07, with an RSI indicating it may be approaching oversold territory. Analysts have set an average target price of $45.0 for Pfizer, with Cantor Fitzgerald rating it Overweight.
February 13, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer has seen a bullish trend in options trading, with a price target range of $25.0 to $30.0. The stock is currently down, trading at $27.07, and may be approaching oversold territory. Analysts have a positive outlook with an average target price of $45.0.
The bullish sentiment in options trading, combined with the current dip in stock price and positive analyst ratings, suggests a potential short-term recovery for Pfizer's stock. The significant options activity, especially the preference for calls, indicates investor confidence in the stock's future performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100